首页> 外国专利> specific binding molecule cultured against human anx-a1 protein, hybridoma cell line, pharmaceutical composition, use of the specific binding molecule and method for treating a t lymphocyte mediated disease in an individual in need thereof

specific binding molecule cultured against human anx-a1 protein, hybridoma cell line, pharmaceutical composition, use of the specific binding molecule and method for treating a t lymphocyte mediated disease in an individual in need thereof

机译:针对人anx-a1蛋白培养的特异性结合分子,杂交瘤细胞系,药物组合物,该特异性结合分子的用途和在需要其的个体中治疗t淋巴细胞介导的疾病的方法

摘要

The present invention provides a specific binding molecule raised against the human Anx-A1 protein having the amino acid sequence shown in FIG. 2A. The present invention also relates to the sue of such a specific binding molecule in the treatment of T cell-mediated disease.
机译:本发明提供了针对具有图1所示氨基酸序列的人Anx-A1蛋白产生的特异性结合分子。 2A。本发明还涉及在治疗T细胞介导的疾病中使用这种特异性结合分子。

著录项

  • 公开/公告号BR112012031107A2

    专利类型

  • 公开/公告日2017-07-25

    原文格式PDF

  • 申请/专利权人 QUEEN MARY & WESTFIELD COLLEGE;

    申请/专利号BR20121131107

  • 发明设计人 FULVIO DACQUISTO;MAURO PERRETTI;

    申请日2011-06-09

  • 分类号C07K16/18;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号